Tidal Care Inc.

For decades, the healthcare industry has struggled against the societal, psychological and physiological effects of a worsening mental health climate. Current treatment options fail to properly address the complexity and pervasiveness of the problem. With the promising research backing the use of psychedelic-assisted treatments in promoting and maintaining mental well-being, there is finally a tool available that can facilitate healing in cases where other methods have failed. For the millions of people around the world struggling to treat a range of mental health conditions such as PTSD, addiction, depression and anxiety, there is hope that psychedelics can help turn the tide and provide a pathway to healing.

We, are Tidal.

At Tidal, it is our mission to support the growth of the nascent psychedelics industry by providing high-quality raw materials and processed products that will be suitable for a range of regulatory jurisdictions and research/treatment applications. By staying closely attuned to industry trends and regulatory updates, Tidal is able to shift with the ever-changing current of the industry.

Are you ready to change the world? Join us, and let’s turn the Tide together.

New Form

Name

First Name

Last Name

Email

Subject

Message

EXECUTIVE TEAM

Shawn has 30+ years of Senior Management and Board Governance experience with a focus on Organizational Structure, Operational Excellence, and Strategic Alliances & Initiatives. Shawn’s experience will be crucial in guiding Tidal through the early stages of growth and development. With a varied background leading both corporate groups and early stage start-ups, Shawn is the ideal person to help bring Tidal to the forefront of the psychedelics space.

Dr. Krista Leicht is a Canadian-trained and Alberta-licensed Medical Doctor and Psychiatrist, who brings over twenty years of Clinical experience to the team. As one of the first people in Canada to be trained and licensed under the new Alberta Psychedelic Drug Treatment Provider Licensing, she is uniquely qualified to provide clinical guidance as well as access to life-saving treatments supplied through the Tidal licensed facilities. Krista is trained in Adult psychiatry, Child and Adolescent Psychiatry, Developmental Medicine and Psychiatry, and has pursued extra post-graduate training in metabolic disorders. Krista’s extensive experience in mental health treatment and her deep-rooted connections with her patients have allowed her to see first-hand the need for paradigm-shifting therapeutics, and the potential that psychedelic compounds have in becoming just that. She is an advocate for access to the safe, research-backed access to psychedelic therapeutics, and will help to direct RND efforts based off of the needs of the ever-shifting and evolving mental-health landscape.

UNIVERSITY OF GUELPH

RESEARCH ALLIANCE

Dr. Jones has applied for and recently received a Health Canada Controlled Drugs and Substances License for the cultivation, analysis, and processing of psilocybin-containing materials.

Dr. Jones’ primary research interest is to better understand why some plants are recalcitrant despite possessing totipotent characteristics, and to develop new approaches to establish integrated plant production systems for applications in plant conservation and the horticultural industry. As a member of the Gosling Research Institute for Plant Preservation (GRIPP), Dr. Jones is involved in a variety of plant conservation initiatives combining micropropagation, cryopreservation, and plant reintroductions. These projects involve a range of endangered plant species, primarily native to Canada, but also from around the world. Dr. Jones will be bringing his extensive experience in plant production and propagation to develop novel cultivation methods for psychedelic fungi that will become a cornerstone of the therapeutic products and high-compliance services that Tidal Care Inc. is bringing to the industry.

Dr. Bozzo is an analytical chemist with research interests in the post-harvest biochemistry and secondary metabolites in plant materials. Dr. Bozzo currently leads an effort on Controlled atmosphere (CA) storage. CA storage is a postharvest management technology designed to limit respiration and ethylene-mediated processes leading to the loss of fruit quality and freshness, which also serves to increase the marketability of climacteric fruit. Dr. Bozzo will be bringing his experience in the realm of plant preservation during harvest, and subsequent analysis to aid in the validation and optimization of proprietary Tidal variants of Psilocybe Cubensis mushrooms. This will serve as an essential step in ensuring the safety, quality, and compliance of therapeutic products and services that Tidal Care Inc. is bringing to the industry.

STRATEGIC ADVISORS

Ryan Maxwell has founded and successfully operated multiple companies, primarily in the Clean Tech, Green Tech, and Real Estate industries. Ryan is a Founding Partner of Terrapin Geothermics Inc., and he co-founded Canada’s largest producer of vermicastings, Annelida Castings Innovations

Brian Wyatt has over 25 years of Marketing and Communication experience and is the former owner of NEWAD Media Inc. (which he sold to BELL in 2019), and the programmatic platform CAMPSITE (which he sold to Broadsign in 2019). Brian also sits on a variety of boards and is invested in numerous companies.